Fixstars Corporation (3687) Stock Price

Fixstars is a software and hardware development company specializing in accelerating large-scale data processing and AI. The company's core services include AI development support, software optimization, and computing infrastructure services utilizing accelerators.

The company serves a diverse customer base including semiconductor manufacturers, automotive companies, manufacturing firms, medical institutions, financial institutions, and research organizations. It handles projects across multiple phases, from research and development through product integration to operations. Revenue is primarily generated from contract development and consulting services, as well as hardware sales, with subscription income from SaaS-based services growing in recent years.

The company's business is divided into two main segments: Solution business and SaaS business. The Solution business provides end-to-end support including algorithm implementation, software optimization, embedded system development, and selection and provision of optimal hardware. The SaaS business offers services such as the quantum computing cloud platform "Fixstars Amplify," breast cancer image diagnosis support tool "METIS Eye," and GPU utilization optimization service "AIBooster."

Based on its medium-term management vision (beginning fiscal year ending September 2024), the company aims to continuously enhance corporate value with operating profit as a key metric. Specifically, the company prioritizes revenue, return on equity, operating profit, and free cash flow, pursuing a strategy that balances operational efficiency with business expansion. The company also emphasizes research and development investment, having invested 450,060 thousand yen in R&D during the most recent consolidated fiscal year, with plans for continued investment going forward.

Priority investment areas include large-scale data processing, AI acceleration, and computing platforms leveraging hardware. The company's competitive differentiation lies in "low-level technology that maximizes hardware performance" and "advanced algorithm implementation capabilities." In addition to custom development services that include software optimization and accelerator deployment support, the company operates proprietary SaaS offerings: the quantum computing cloud platform "Fixstars Amplify," the breast cancer imaging diagnostic support tool "METIS Eye," and "AIBooster" for improving GPU utilization efficiency. The company is expanding subscription-based revenue alongside contract development income.

For new market development and business expansion, the company leverages its existing customer base in semiconductors, automotive, manufacturing, healthcare, finance, and research institutions while focusing on recurring revenue models through SaaS services to stabilize earnings. Additionally, the company is pursuing new business development to capture leading global market share in specific sectors and convert "winner-takes-all" dynamics into growth opportunities. As of September 2025, the company has 334 employees, with over 90% working as engineers. The company is strengthening its workforce through aggressive hiring, in-house training, and a professional career track system.

Regarding technological innovation, the company continues to invest in low-level optimization technology and algorithm improvements to address hardware transitions such as multicore processors and specialized chips. Specific initiatives include enhancing and commercializing proprietary products, continuing R&D investment, systematizing internal knowledge and developing educational programs to horizontally deploy technical capabilities, and strengthening security measures and internal governance to simultaneously improve product reliability and brand value.